Dextech Medical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Anders Holmberg
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 21yrs |
| CEO ownership | 8.5% |
| Management average tenure | no data |
| Board average tenure | 10.8yrs |
Recent management updates
Recent updates
Dextech Medical (NGM:DEX) Is In A Good Position To Deliver On Growth Plans
Jan 10
Companies Like Dextech Medical (NGM:DEX) Are In A Position To Invest In Growth
Sep 20We're Not Very Worried About Dextech Medical's (NGM:DEX) Cash Burn Rate
Jun 03What Kind Of Shareholders Hold The Majority In Dextech Medical AB's (NGM:DEX) Shares?
Feb 17
Companies Like Dextech Medical (NGM:DEX) Are In A Position To Invest In Growth
Dec 12CEO
Anders Holmberg (73 yo)
21yrs
Tenure
SEK 596,112
Compensation
Mr. Anders Ragnarsson Holmberg, M.D. is the Founder of Dextech Medical AB (publ) and serves as its Chief Executive Officer and Managing Director and served as its President. Mr. Holmberg has been a Directo...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 20.4yrs | SEK 596.11k | 8.51% SEK 6.1m | |
| Director | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 10.8yrs | no data | no data | |
| Director | no data | no data | 21.47% SEK 15.5m | |
| Director | 11.8yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | 1.56% SEK 1.1m | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of the Board | 2.7yrs | no data | no data |
10.8yrs
Average Tenure
71yo
Average Age
Experienced Board: DEX's board of directors are seasoned and experienced ( 10.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 02:26 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dextech Medical AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|